Chen et al. reported that MYH9 significantly enhances the stemness of lung cancer cells (LCCs) by regulating the expression of cancer stem cell (CSC) markers, including CD44, SOX2, Nanog, CD133, and OCT4. Here, MYH9 is linked to lung cancer.